Current Off-Label Pharmacotherapeutics in the Management of Novel Coronavirus Disease (COVID-19)

NeuroPharmac Journal
doi 10.37881/1.511
Full Text
Abstract

Available in full text

Date
Authors
Publisher

NeuroPharmac Journal